Dr. Ellen Ritchie Reflects on Research Underway in Myeloproliferative Neoplasms

Researchers are examining a variety of therapeutic regimens for patients with myeloproliferative neoplasms (MPNs), as well as working to obtain a deeper understanding of the biology of these conditions. This includes investigating combining new biologic agents with FDA-approved therapies in order to improve response rates and quality of life (QOL). Dr. Ellen Ritchie speaks with OncLive regarding ongoing research in this area. Learn more.

Richard T. Silver MD Myeloproliferative Neoplasms Center 525 East 70th St., Starr Pavillion, 3rd Floor New York, NY 10021 SilverMPNCenter@med.cornell.edu